Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew ManganGerman Center for Neurodegenerative Diseases (DZNE), Bonn, GermanyEdward J. OlhavaIFM Therapeutics, Boston, MA, USAWilliam RoushIFM Therapeutics, Boston, MA, USAH. Martin SeidelIFM Therapeutics, Boston, MA, USAGary D. GlickIFM Therapeutics, Boston, MA, USAEicke LatzDepartment of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA
2018en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба